BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7263802)

  • 21. [Determination of pilocarpine and isopilocarpine by high performance liquid chromatography in normal phase. The stability of eye drops with a pilocarpine base and comparison of this method with a colorimetric method using hydroxylamine].
    Balansard G; Vidal E; Guigues M; Ollivier B; de Meo M
    Pharm Acta Helv; 1986; 61(2):47-50. PubMed ID: 3960937
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantitative analysis of degradation products in pilocarpine hydrochloride ophthalmic formulations.
    Neville GA; Hasan FB; Smith IC
    J Pharm Sci; 1977 May; 66(5):638-42. PubMed ID: 17713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rapid semiquantitative evaluation by thin-layer chromatography of pilo- and isopilocarpic acids in eyedrops with a pilocarpine base].
    Durif C; Ribes M; Kister G; Puech A
    Pharm Acta Helv; 1986; 61(5-6):135-8. PubMed ID: 3725811
    [No Abstract]   [Full Text] [Related]  

  • 24. High-performance liquid chromatographic assay for pilocarpine in aqueous humor.
    Rendi MA; Ellis PP; Gal J
    J Chromatogr; 1984 Dec; 336(2):337-44. PubMed ID: 6530466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilocarpine prodrugs I. Synthesis, physicochemical properties and kinetics of lactonization of pilocarpic acid esters.
    Bundgaard H; Falch E; Larsen C; Mikkelson TJ
    J Pharm Sci; 1986 Jan; 75(1):36-43. PubMed ID: 3958903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of pilocarpic acid in human plasma by capillary gas chromatography with mass-selective detection.
    Birk KL; Dru JD; Hsieh JY; Demetriades JL; Matuszewski BK; Bayne WF; Woolf EJ; Cairns AM; Rogers JD; Musson DG
    J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):93-102. PubMed ID: 9869369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of commercial pilocarpine preparations by high-performance liquid chromatography.
    Drake MV; O'Donnell JJ; Sandman RP
    J Pharm Sci; 1982 Mar; 71(3):358-9. PubMed ID: 7069599
    [No Abstract]   [Full Text] [Related]  

  • 28. Problems connected with HPLC separation of pilocarpine from its degradation products by means of silica gel and water-based mobile phase.
    Vespalec R; Fiedorová M; Subert J
    Pharmazie; 1988 Oct; 43(10):689-91. PubMed ID: 2850587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-speed liquid chromatographic determination of pilocarpine in pharmaceutical dosage forms.
    Khalil SK
    J Pharm Sci; 1977 Nov; 66(11):1625-6. PubMed ID: 915743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of pilocarpine and its trans epimer, isopilocarpine, by capillary electrophoresis.
    Baeyens W; Weiss G; Van Der Weken G; Van Den Bossche W
    J Chromatogr; 1993 May; 638(2):319-26. PubMed ID: 8331141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of pilocarpine ophthalmic solutions.
    Pilatti C; Torre MC; Chiale C; Spinetto M
    Drug Dev Ind Pharm; 1999 Jun; 25(6):801-5. PubMed ID: 10349567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of pilocarpine, physostigmine, its degradation product rubreserine and preservatives by high-performance liquid chromatography.
    Kneczke M
    J Chromatogr; 1980 Oct; 198(4):529-33. PubMed ID: 7440688
    [No Abstract]   [Full Text] [Related]  

  • 33. High-performance liquid chromatographic determination of pilocarpine in aqueous humor: derivatization by quaternization of methylimidazole tertiary amine group.
    Mitra AK; Baustian CL; Mikkelson TJ
    J Pharm Sci; 1980 May; 69(3):257-61. PubMed ID: 7381697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative intraocular levels of pilocarpine achieved with drops and repository preparations.
    Ellis PP; Riegel MA
    J Ocul Pharmacol; 1987; 3(2):121-8. PubMed ID: 3503909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and identification of pilocarpic acid diesters, prodrugs of pilocarpine.
    Järvinen T; Auriola S; Peura P; Suhonen P; Urtti A; Vepsäläinen J
    J Pharm Biomed Anal; 1991; 9(6):457-64. PubMed ID: 1747398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of d-pilocarpine-N-14CH3.
    DeGraw JI; Engstrom JS; Willis E
    J Pharm Sci; 1975 Oct; 64(10):1700-1. PubMed ID: 1185540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilocarpine prodrugs. II. Synthesis, stability, bioconversion, and physicochemical properties of sequentially labile pilocarpine acid diesters.
    Bundgaard H; Falch E; Larsen C; Mosher GL; Mikkelson TJ
    J Pharm Sci; 1986 Aug; 75(8):775-83. PubMed ID: 3772750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New spectrophotometric assay for pilocarpine.
    El-Masry S; Soliman R
    J Assoc Off Anal Chem; 1980 Jul; 63(4):689-91. PubMed ID: 7400081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The identification of atropine, homatropine, acopolamine and pilocarpine as impurities in eye drops].
    Dijkhuis IC
    Pharm Weekbl; 1969 Oct; 104(42):1317-24. PubMed ID: 5345446
    [No Abstract]   [Full Text] [Related]  

  • 40. [Determination of ethylmorphine chloride, pilocarpine chloride and tetracaine chloride in drops and ointments for the eye].
    Banović V; Popović R
    Vojnosanit Pregl; 1985; 42(3):202-5. PubMed ID: 4024515
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.